Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis
Author:
Funder
Bayer Healthcare Company Ltd., Beijing, China
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s40123-024-00915-0.pdf
Reference41 articles.
1. Yucel OE, Birinci H, Sullu Y. The short-term efficacy of intravitreal ranibizumab, aflibercept and dexamethasone implant in the treatment of macular edema due to non-ischemic central retinal vein occlusion. Int Ophthalmol. 2019;39:891–901. https://doi.org/10.1007/s10792-018-0890-6.
2. Regnier SA, Larsen M, Bezlyak V, Allen F. Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis. BMJ Open. 2015;5: e007527. https://doi.org/10.1136/bmjopen-2014-007527.
3. Coscas G, Loewenstein A, Augustin A, et al. Management of retinal vein occlusion–consensus document. Ophthalmologica. 2011;226:4–28. https://doi.org/10.1159/000327391.
4. Qian T, Zhao M, Wan Y, Li M, Xu X. Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion. BMJ Open. 2018;8: e022700. https://doi.org/10.1136/bmjopen-2018-022700.
5. Ehlers JP, Kim SJ, Yeh S, et al. Therapies for macular edema associated with branch retinal vein occlusion: a report by the American Academy of Ophthalmology. Ophthalmology. 2017;124:1412–23. https://doi.org/10.1016/j.ophtha.2017.03.060.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unilateral Painless Vision Loss Detected Incidentally During the Driver's Health Examination at the Family Medicine Polyclinic: Case Report;Ağrı Tıp Fakültesi Dergisi;2024-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3